Table of Contents
2019-2024 Global Human Microbiome Market Report (Status and Outlook)
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Microbiome Market Size 2014-2024
2.1.2 Human Microbiome Market Size CAGR by Region
2.2 Human Microbiome Segment by Type
2.2.1 Gastrointestinal Tract Human Micobiome
2.2.2 Urogenital Tract Human Micobiome
2.2.3 Other
2.3 Human Microbiome Market Size by Type
2.3.1 Global Human Microbiome Market Size Market Share by Type (2014-2019)
2.3.2 Global Human Microbiome Market Size Growth Rate by Type (2014-2019)
2.4 Human Microbiome Segment by Application
2.4.1 Treatment
2.4.2 Diagnosis
2.5 Human Microbiome Market Size by Application
2.5.1 Global Human Microbiome Market Size Market Share by Application (2014-2019)
2.5.2 Global Human Microbiome Market Size Growth Rate by Application (2014-2019)
3 Global Human Microbiome by Players
3.1 Global Human Microbiome Market Size Market Share by Players
3.1.1 Global Human Microbiome Market Size by Players (2017-2019)
3.1.2 Global Human Microbiome Market Size Market Share by Players (2017-2019)
3.2 Global Human Microbiome Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Human Microbiome by Regions
4.1 Human Microbiome Market Size by Regions
4.2 Americas Human Microbiome Market Size Growth
4.3 APAC Human Microbiome Market Size Growth
4.4 Europe Human Microbiome Market Size Growth
4.5 Middle East & Africa Human Microbiome Market Size Growth
5 Americas
5.1 Americas Human Microbiome Market Size by Countries
5.2 Americas Human Microbiome Market Size by Type
5.3 Americas Human Microbiome Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Human Microbiome Market Size by Countries
6.2 APAC Human Microbiome Market Size by Type
6.3 APAC Human Microbiome Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Human Microbiome by Countries
7.2 Europe Human Microbiome Market Size by Type
7.3 Europe Human Microbiome Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Human Microbiome by Countries
8.2 Middle East & Africa Human Microbiome Market Size by Type
8.3 Middle East & Africa Human Microbiome Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Human Microbiome Market Forecast
10.1 Global Human Microbiome Market Size Forecast (2019-2024)
10.2 Global Human Microbiome Forecast by Regions
10.2.1 Global Human Microbiome Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Human Microbiome Forecast by Type
10.8 Global Human Microbiome Forecast by Application
11 Key Players Analysis
11.1 Vedanta
11.1.1 Company Details
11.1.2 Human Microbiome Product Offered
11.1.3 Vedanta Human Microbiome Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Vedanta News
11.2 Seres Therapeutics
11.2.1 Company Details
11.2.2 Human Microbiome Product Offered
11.2.3 Seres Therapeutics Human Microbiome Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Seres Therapeutics News
11.3 Second Genome
11.3.1 Company Details
11.3.2 Human Microbiome Product Offered
11.3.3 Second Genome Human Microbiome Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Second Genome News
11.4 Rebiotix
11.4.1 Company Details
11.4.2 Human Microbiome Product Offered
11.4.3 Rebiotix Human Microbiome Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Rebiotix News
11.5 ActoGeniX
11.5.1 Company Details
11.5.2 Human Microbiome Product Offered
11.5.3 ActoGeniX Human Microbiome Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 ActoGeniX News
11.6 Enterome BioScience
11.6.1 Company Details
11.6.2 Human Microbiome Product Offered
11.6.3 Enterome BioScience Human Microbiome Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Enterome BioScience News
11.7 AvidBiotics
11.7.1 Company Details
11.7.2 Human Microbiome Product Offered
11.7.3 AvidBiotics Human Microbiome Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 AvidBiotics News
11.8 4D Pharma Research Ltd
11.8.1 Company Details
11.8.2 Human Microbiome Product Offered
11.8.3 4D Pharma Research Ltd Human Microbiome Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 4D Pharma Research Ltd News
11.9 Enterologics
11.9.1 Company Details
11.9.2 Human Microbiome Product Offered
11.9.3 Enterologics Human Microbiome Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Enterologics News
11.10 Metabogen
11.10.1 Company Details
11.10.2 Human Microbiome Product Offered
11.10.3 Metabogen Human Microbiome Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 Metabogen News
11.11 Metabiomics
11.12 Ritter Pharmaceuticals
11.13 Osel
11.14 Symberix
11.15 Miomics
11.16 Symbiotix Biotherapies
11.17 MicroBiome Therapeutics LLC
12 Research Findings and Conclusion